$44.00
-0.09 (-0.20%)
Open$44.40
Previous Close$44.09
Day High$44.52
Day Low$43.56
52W High$71.50
52W Low$8.73
Volume—
Avg Volume1.14M
Market Cap3.06B
P/E Ratio—
EPS$-4.05
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
-60.2% upside
Current
$44.00
$44.00
Target
$17.51
$17.51
$11.65
$17.51 avg
$27.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.43M | 36.48M | 366.27M |
| Net Income | -240,130,623 | -405,702,197 | 43.81M |
| Profit Margin | -1,236.0% | -1,174.2% | 12.0% |
| EBITDA | -205,882,758 | -367,164,670 | 53.48M |
| Free Cash Flow | — | — | 19.66M |
| Rev Growth | -46.7% | -46.7% | -4.9% |
| Debt/Equity | 2.63 | 2.63 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |